Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (13237)	9/30/2004 1:47:34 PM
From: Biomaven	Respond to of 52153

Triptans are pretty idiosyncratic - what works great for one person doesn't always work for another. I also currently use Maxalt, but my latest research suggests almotriptan (Axert from J&J) is now considered best of breed, with Pfizer's Relpax and some others perhaps second. Unfortunately my health insurer's formulary doesn't agree with my ratings. <g> One interesting fact about Maxalt - it comes in an instant dissolve version and a tablet version. Care to guess which has the quicker absorption? The tablet, consistently. Peter